Loading...
Loading...
AVAI BIO, INC.
AVAI BIO, INC.. Spoken Alpha tracks AVAI's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks AVAI's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AVAI.
curl https://api.spokenalpha.com/v1/companies/AVAI| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.41 | $1.57 | -10.2% | +2.1% | +3.4% |
| Q4 FY2026 | $1.33 | $1.55 | -14.2% | -4.2% | -1.8% |
| Q3 FY2026 | $1.64 | $1.68 | -2.5% | +6.9% | +8.8% |
| Q2 FY2026 | $1.44 | $1.63 | -11.6% | -1.5% | -4.4% |
| Q1 FY2025 | $1.41 | $1.43 | -1.4% | +1.8% | +3.8% |
| Q4 FY2025 | $1.50 | $1.58 | -5.1% | +3.9% | +5.9% |
| Q3 FY2025 | $1.46 | $1.49 | -2.1% | -4.2% | -5.9% |
| Q2 FY2025 | $1.35 | $1.50 | -10.2% | -1.5% | -4.3% |
| Q1 FY2024 | $1.51 | $1.52 | -0.8% | +6.6% | +9.5% |
| Q4 FY2024 | $1.39 | $1.59 | -12.4% | +5.2% | +6.6% |